John Lister is an Oncology physician affiliated with Allegheny Health Network. OpenAlex indexes 304 publications with 10,109 citations (h-index 42); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4815 Liberty Ave Ste 322
Pittsburgh, PA 152242156
Telephone
412-578-4484Provider last certified this registry record 1 Oct 2020.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
- Astellas Pharma US IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
29.2%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor29.2%Acyclovir100%Part D≥25 patientsCancer & immunology
18.7%Kinase inhibitor11.6%Imbruvica38%Jakafi22%Tasigna21%Imatinib Mesylate19%Part D<11 patientsBCL-2 Inhibitor2.6%Venclexta100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
13.9%Corticosteroid4.4%Prednisone100%Part D<11 patientsPotassium supplement3.9%Potassium Chloride100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1997–1997 per NIH RePORTER. The latest:
- PIVOTAL PHASE III STUDY--IDEC-C2B8 (IDEC-102) IN FOLLICULAR LYMPHOMA
University of Pittsburgh at Pittsburgh
FY1997M01RR000056
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Bridging the gap: a palliative care consultation service in a hematological malignancy–bone marrow transplant unit
The Journal of Community and Supportive Oncology
2014 - Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study
British Journal of Haematology
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Kalathil Sureshkumar, MD
Allegheny Health Network
Susan Manzi, MD
Allegheny Health Network
Blair Jobe, MD
Allegheny Health Network
Sushil Beriwal, MD
Allegheny Health Network
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”